Search

everythinglearnresearchcommunity

for

Search:↓

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

The review highlights the importance of stem cells in hair health and suggests new treatment strategies for hair loss conditions.

Platelet-rich plasma (PRP) may help with various hair loss types, but more research is needed to find the best use method.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Topical DPCP is somewhat effective for hair loss in alopecia areata, but more research is needed.

Exclamation mark hairs suggest early scalp disease, while white dots indicate it's chronic.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

The study concluded that Frontal fibrosing alopecia can affect younger people, is often missed in men, and may be autoimmune-related.

Various substances, including cosmetic sponges, vein glue, chai tea, skincare products, and medicaments, can cause allergic contact dermatitis, and healthcare workers often react to N95 masks.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Increased scalp sweating in frontal fibrosing alopecia may be linked to local skin inflammation.

Low-dose oral isotretinoin improved hair loss and facial bumps in patients with a specific type of hair loss.

Understanding the cause of bitemporal hair loss is key to deciding the right treatment.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

Dermatologists often neglect hair disorders due to complexity and lack of clear treatments, impacting patient care and highlighting the need for better education and interest in this area.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Dr. Rodney Sinclair uses a detailed grading system to diagnose female pattern hair loss, recommends daily spironolactone and minoxidil for treatment, and believes genetics play a role in the condition.

The treatment helped reduce symptoms and stabilize the hairline in most patients with Frontal Fibrosing Alopecia, but hair regrowth was limited.

Most patients with frontal fibrosing alopecia stabilized with treatment, especially younger ones, using intralesional corticosteroids and tacrolimus.

Smoking is linked to more hair loss and premature graying compared to nonsmokers.

Frontal fibrosing alopecia in families shows similar signs to individual cases and may have a genetic link.

The conclusion is that FFA and LPP have similar scalp biopsy features, making them hard to distinguish histologically, and FFA may be a specific kind of scarring hair loss.

Dermoscopy is useful for diagnosing various skin, hair, and nail disorders and can reduce the need for biopsies.

A 60-year-old man with a long-term balding condition also developed a rare hair loss condition usually seen in postmenopausal women.

Eyebrow loss in frontal fibrosing alopecia is common and may be linked to other health issues.

Intralesional triamcinolone injections can effectively stop frontal fibrosing alopecia with minimal side effects.

Frontal Fibrosing Alopecia might be an autoimmune disease.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Two patients with skin lupus were mistakenly thought to have a different scalp condition but improved with lupus treatment.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.